ADM Tronics Un AI Stock Analysis
Want to see ADMT full AI Analyst Report?
ADM Tronics Un (ADMT) AI Stock Analysis
ADM Tronics Un
(Other OTC:ADMT)
The score is held down primarily by weak financial performance (revenue contraction, continued losses, and negative operating/free cash flow) and a loss-based valuation signal (negative P/E). These negatives are partially offset by strong technical momentum (price above key moving averages with a positive MACD) and a constructive corporate event (private placement funding and board reconstitution).
ADM Tronics Un (ADMT) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $8.08M
- Dividend Yield
- ―
- Average Volume (3M)
- 50.06K
- Price to Earnings (P/E)
- -20.6
- Beta (1Y)
- -0.13
- Revenue Growth
- -2.21%
- EPS Growth
- -490.00%
- Country
- US
- Employees
- 30
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
ADM Tronics Un Business Overview & Revenue Model
Company Description
ADM Tronics Unlimited, Inc. (ADMT), established in 1969 and headquartered in Northvale, New Jersey, is a company that develops, manufactures, and markets electronic solutions. Its products are primarily designed for non-invasive medical applications,...
ADM Tronics Un Financial Statement Overview
Summary
Financials are weak: TTM revenue fell ~19% and the company remains unprofitable with negative operating income and net loss. Cash flow is a major drag with negative TTM operating cash flow and free cash flow, increasing funding risk. The balance sheet is workable (positive equity) but leverage has risen (debt-to-equity ~1.0), reducing flexibility if results don’t improve.
Income Statement
34NegativeBalance Sheet
46NeutralCash Flow
28Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.35M | 3.35M | 3.20M | 2.97M | 3.68M | 3.21M |
| Gross Profit | 1.36M | 1.36M | 1.40M | 1.12M | 1.66M | 1.25M |
| EBITDA | 59.65K | -60.35K | 12.29K | -732.58K | 80.35K | -1.02M |
| Net Income | -100.37K | -100.37K | -123.06K | -877.22K | -96.32K | -1.38M |
Balance Sheet | ||||||
| Total Assets | 1.83M | 1.83M | 2.13M | 2.14M | 3.09M | 3.35M |
| Cash, Cash Equivalents and Short-Term Investments | 255.73K | 255.73K | 382.97K | 537.04K | 1.00M | 1.04M |
| Total Debt | 741.26K | 741.26K | 846.86K | 918.33K | 752.69K | 1.02M |
| Total Liabilities | 1.26M | 1.26M | 1.46M | 1.45M | 1.52M | 1.98M |
| Stockholders Equity | 570.97K | 570.97K | 671.35K | 692.39K | 1.57M | 1.37M |
Cash Flow | ||||||
| Free Cash Flow | -124.06K | -124.06K | 9,978 | -724.40K | 125.02K | -574.95K |
| Operating Cash Flow | -124.06K | -124.06K | 9,978 | -709.89K | 125.02K | -574.95K |
| Investing Cash Flow | 0 | 0 | -225.75K | -14.52K | 0 | 0 |
| Financing Cash Flow | -3,180 | -3,180 | 61.70K | 257.71K | -258.56K | 66.50K |
ADM Tronics Un Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADMT, the sentiment is Positive. The current price of 0.12 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.06, and above the 200-day MA of 0.07, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 70.20 is Negative, neither overbought nor oversold. The STOCH value of 70.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ADMT.
ADM Tronics Un Risk Analysis
ADM Tronics Un disclosed 17 risk factors in its most recent earnings report. ADM Tronics Un reported the most risks in the "Production" category.
Latest Risks Added
0 New RisksADM Tronics Un Peers Comparison
Overall Rating
ADMT49Neutral
MOVE47Neutral
AEMD44Neutral
AMIX40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 49Neutral | $8.08M | -20.60 | -56.20% | ― | -2.21% | -490.00% | |
| 47Neutral | $174.95M | -0.35 | -9.44% | ― | 1767.40% | 19.21% | |
| 44Neutral | $8.49M | -0.50 | -141.22% | ― | ― | 90.69% | |
| 40Underperform | $2.80M | -0.07 | -191.88% | ― | ― | 81.59% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ADMT | ADM Tronics Un | 0.12 | 0.02 | 21.43% | |
| AEMD | Aethlon | 5.29 | -14.96 | -73.88% | |
| MOVE | Corvex, Inc. | 4.47 | -3.00 | -40.16% | |
| AMIX | Autonomix Medical, Inc. | 1.37 | -22.78 | -94.33% |
ADM Tronics Un Corporate Events
ADM Tronics Un launches strategic private placement and board overhaul
PositiveADM Tronics Unlimited, Inc., a long-established technology company in medical electronic devices, specialty water-based chemicals and FDA-registered engineering and contract manufacturing, is based in Northvale, N.J. and serves healthcare and industr...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 12, 2026
